InvestorsHub Logo
Followers 829
Posts 119628
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 2763

Thursday, 10/25/2018 5:05:27 PM

Thursday, October 25, 2018 5:05:27 PM

Post# of 4860
GILD 3Q18 results—HCV sales=$902M,-10% QoQ:

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=2373553

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDEyNDE4fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636759229545616779

3Q18 US HCV sales were $487M, -10% QoQ; 3Q18 ex-US HCV sales were $415M, -10% QoQ (see slide #25).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News